Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DCLRE1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ATXN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAAA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAF9B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2CB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NINJ1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM58A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUBB4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ESCO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SS18L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NECAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPAN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF343 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNFRSF10A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR4656 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RTCB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LGALS8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNPEP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on